Merrill Downgrades Duane Reade to 'Sell'

Analyst Monica Aggarwal says she was surprised by the degree of the drug-store chain's earnings shortfall

Merrill Lynch downgraded Duane Reade (DRD ) to sell from neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.